☰

Alyssa Bouska, Ph.D. - Publications

Affiliations: 
2008 University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Dong G, Li Y, Lee L, Liu X, Shi Y, Liu X, Bouska A, Gong Q, Kong L, Wang J, Lou CH, McKeithan TW, Iqbal J, Chan WC. Genetic manipulation of primary human natural killer cells to investigate the functional and oncogenic roles of PRDM1. Haematologica. PMID 32732362 DOI: 10.3324/Haematol.2020.254276  0.368
2019 Amador C, Greiner TC, Heavican TB, Smith LM, Galvis KT, Lone WG, Bouska A, D'amore F, Bjerregård Pedersen M, Pileri SA, Agostinelli C, Feldman AL, Rosenwald A, Ott G, Mottok A, et al. Reproducing the Molecular Subclassification of Peripheral T-cell Lymphoma-NOS by Immunohistochemistry. Blood. PMID 31562134 DOI: 10.1182/Blood.2019000779  0.379
2019 Jain N, Hartert K, Tadros S, Fiskus W, Havranek O, Ma MCJ, Bouska A, Heavican T, Kumar D, Deng Q, Moore D, Pak C, Liu CL, Gentles AJ, Hartmann E, et al. Targetable genetic alterations of () drive immunoglobulin expression in diffuse large B cell lymphoma. Science Translational Medicine. 11. PMID 31217338 DOI: 10.1126/Scitranslmed.Aav5599  0.407
2019 Heavican TB, Bouska A, Yu J, Lone W, Amador C, Gong Q, Zhang W, Li Y, Dave BJ, Nairismägi ML, Greiner TC, Vose J, Weisenburger DD, Lachel C, Wang C, et al. Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. Blood. PMID 30782609 DOI: 10.1182/Blood-2018-09-872549  0.415
2019 Lone W, Bouska A, Herek T, Amador C, Saumyaranajn M, Jiayu Y, Heavican T, Pileri SA, McKeithan T, Chan WC, Iqbal J. Genome-Wide microRNA Expression Profiling in Molecular Subgroups of Peripheral T-Cell Lymphoma Identified Role of Mir-126 in T-Cell Lymphomagenesis Blood. 134: 2767-2767. DOI: 10.1182/Blood-2019-129327  0.304
2019 Song JY, Egan C, Bouska A, Zhang W, Gong Q, Venkataraman G, Herrera AF, Chen L, Ottesen R, Niland J, Bedell V, Valle-Catuna M, Murata-Collins J, Weisenburger DD, Iqbal J, et al. Genomic Characterization of Diffuse Large B-Cell Lymphoma Transformation from Nodular Lymphocyte Predominant Hodgkin Lymphoma Blood. 134: 1486-1486. DOI: 10.1182/Blood-2019-125095  0.304
2018 Umakanthan JM, Iqbal J, Batlevi CL, Bouska A, Smith LM, Shostrom V, Nutsch H, William BM, Gregory Bociek R, Lunning M, Bierman P, Younes A, Armitage JO, Vose JM. Phase I/II study of dasatinib and exploratory genomic analysis in relapsed or refractory non-Hodgkin lymphoma. British Journal of Haematology. PMID 30520026 DOI: 10.1111/Bjh.15702  0.306
2018 d'Amore F, Leppä S, Silva MGd, Relander T, Lauritzsen GF, Brown PDN, Pezzutto A, Doorduijn JK, Weidmann E, van Gelder M, Hoof AV, Christiansen I, Fagerli UM, Hagberg H, Lugtenburg P, ... ... Bouska A, et al. Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant Blood. 132: 998-998. DOI: 10.1182/Blood-2018-99-110429  0.324
2017 Bouska A, Bi C, Lone W, Zhang W, Kedwaii A, Heavican T, Lachel CM, Yu J, Ferro R, Eldorghamy N, Greiner TC, Vose J, Weisenburger DD, Gascoyne RD, Rosenwald A, et al. Adult High Grade B-cell Lymphoma with Burkitt Lymphoma Signature: Genomic features and Potential Therapeutic Targets. Blood. PMID 28801451 DOI: 10.1182/Blood-2017-02-767335  0.384
2016 Bouska A, Zhang W, Gong Q, Iqbal J, Scuto A, Vose J, Ludvigsen M, Fu K, Weisenburger DD, Greiner TC, Gascoyne RD, Rosenwald A, Ott G, Campo E, Rimsza LM, et al. Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma. Leukemia. PMID 27389057 DOI: 10.1038/Leu.2016.175  0.356
2016 Heavican TB, Yu J, Bouska A, Greiner TC, Lachel CM, Wang C, Dave BJ, Amador CC, Fu K, Vose JM, Weisenburger DD, Gascoyne RD, Hartmann S, Pedersen MB, Wilcox R, et al. Molecular Subgroups of Peripheral T-Cell Lymphoma Evolve By Distinct Genetic Pathways Blood. 128: 4096-4096. DOI: 10.1182/Blood.V128.22.4096.4096  0.4
2016 Bouska A, Bi C, Lone W, Zhang W, Kedwaii A, Heavican TB, Lachel CM, Yu J, Fu K, Ferro RA, Eldorghamy N, Greiner TC, Vose JM, Weisenburger DD, Gascoyne RD, et al. Comprehensive Genomic Analysis of Adult Burkitt Lymphoma Identifies the B-Cell Receptor Signaling Pathway As a Potential Therapeutic Target Blood. 128: 4095-4095. DOI: 10.1182/Blood.V128.22.4095.4095  0.407
2016 Hartert K, Tadros S, Bouska A, Moore D, Pak C, Heavican T, Liu CL, Gentles AJ, Hartmann EM, Kridel R, Smedby KE, Juliusson G, Rosenquist R, Gascoyne RD, Rosenwald A, et al. DNA Copy Number Gains of TCF4 (E2-2) Are Associated with Poor Outcome in Diffuse Large B-Cell Lymphoma Blood. 128: 2686-2686. DOI: 10.1182/Blood.V128.22.2686.2686  0.465
2016 Yu J, Bouska A, Lone W, Bi C, Heavican T, Fu K, Greiner TC, Chan WC, Iqbal J. Long Non Coding RNA Signatures with Diagnostic and Prognostic Significance in Aggressive B-Cell Lymphoma Blood. 128: 1759-1759. DOI: 10.1182/Blood.V128.22.1759.1759  0.355
2015 Iqbal J, Naushad H, Bi C, Yu J, Bouska A, Rohr J, Chao W, Fu K, Chan WC, Vose JM. Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis? Blood Reviews. PMID 26432520 DOI: 10.1016/J.Blre.2015.08.002  0.317
2015 Wang C, McKeithan TW, Gong Q, Zhang W, Bouska A, Rosenwald A, Gascoyne RD, Wu X, Wang J, Muhammad Z, Jiang B, Rohr J, Cannon A, Steidl C, Fu K, et al. IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma. Blood. PMID 26268241 DOI: 10.1182/Blood-2015-05-644591  0.371
2015 Küçük C, Hu X, Jiang B, Klinkebiel D, Geng H, Gong Q, Bouska A, Iqbal J, Gaulard P, McKeithan TW, Chan WC. Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1699-711. PMID 25614448 DOI: 10.1158/1078-0432.Ccr-14-1216  0.334
2015 Carrillo AM, Bouska A, Arrate MP, Eischen CM. Mdmx promotes genomic instability independent of p53 and Mdm2. Oncogene. 34: 846-56. PMID 24608433 DOI: 10.1038/Onc.2014.27  0.748
2014 Oricchio E, Ciriello G, Jiang M, Boice MH, Schatz JH, Heguy A, Viale A, de Stanchina E, Teruya-Feldstein J, Bouska A, McKeithan T, Sander C, Tam W, Seshan VE, Chan WC, et al. Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy. The Journal of Experimental Medicine. 211: 1379-91. PMID 24913233 DOI: 10.1084/Jem.20132120  0.42
2014 Bouska A, McKeithan TW, Deffenbacher KE, Lachel C, Wright GW, Iqbal J, Smith LM, Zhang W, Kucuk C, Rinaldi A, Bertoni F, Fitzgibbon J, Fu K, Weisenburger DD, Greiner TC, et al. Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma. Blood. 123: 1681-90. PMID 24037725 DOI: 10.1182/Blood-2013-05-500595  0.377
2014 Carrillo AM, Bouska A, Arrate MP, Eischen CM. Mdmx promotes genomic instability independent of p53 and Mdm2 Oncogene. DOI: 10.1038/onc.2014.27  0.741
2013 Kucuk C, Hu X, Jiang B, Gaulard P, Klinkebiel D, Geng H, Bouska A, Iqbal J, McKeithan T, Chan WC. Global Methylation Analysis Reveals Novel Candidate Tumor Suppressor Genes In Natural Killer Cell Lymphomas Blood. 122: 1262-1262. DOI: 10.1182/Blood.V122.21.1262.1262  0.353
2012 Bouska A, McKeithan T, Deffenbacher KE, Lachel C, Wright GW, Iqbal J, Smith LM, Liu Z, Kucuk C, Bertoni F, Rinaldi A, Fitzgibbon J, Fu K, Weisenburger DD, Greiner TC, et al. Genetic Abnormalities in Follicular Lymphoma and Transformed Follicular Lymphoma. Blood. 120: 2648-2648. DOI: 10.1182/Blood.V120.21.2648.2648  0.398
2011 Lushnikova T, Bouska A, Odvody J, Dupont WD, Eischen CM. Aging mice have increased chromosome instability that is exacerbated by elevated Mdm2 expression. Oncogene. 30: 4622-31. PMID 21602883 DOI: 10.1038/Onc.2011.172  0.608
2010 Ramachandrareddy H, Bouska A, Shen Y, Ji M, Rizzino A, Chan WC, McKeithan TW. BCL6 promoter interacts with far upstream sequences with greatly enhanced activating histone modifications in germinal center B cells. Proceedings of the National Academy of Sciences of the United States of America. 107: 11930-5. PMID 20547840 DOI: 10.1073/Pnas.1004962107  0.318
2009 Bouska A, Eischen CM. Murine double minute 2: p53-independent roads lead to genome instability or death. Trends in Biochemical Sciences. 34: 279-86. PMID 19447627 DOI: 10.1016/J.Tibs.2009.02.006  0.716
2009 Bouska A, Eischen CM. Mdm2 affects genome stability independent of p53. Cancer Research. 69: 1697-701. PMID 19244108 DOI: 10.1158/0008-5472.Can-08-3732  0.72
2008 Bouska A, Lushnikova T, Plaza S, Eischen CM. Mdm2 promotes genetic instability and transformation independent of p53. Molecular and Cellular Biology. 28: 4862-74. PMID 18541670 DOI: 10.1128/Mcb.01584-07  0.739
2005 Alt JR, Bouska A, Fernandez MR, Cerny RL, Xiao H, Eischen CM. Mdm2 binds to Nbs1 at sites of DNA damage and regulates double strand break repair. The Journal of Biological Chemistry. 280: 18771-81. PMID 15734743 DOI: 10.1074/Jbc.M413387200  0.62
Show low-probability matches.